IGC Pharma: Prins Reports Ownership Change

TL;DR

IGC Pharma insider Prins changed his stock ownership on 4/1/26. Details TBD.

AI Summary

On April 1, 2026, Richard K. Prins reported a change in beneficial ownership of securities for IGC Pharma, Inc. The filing details transactions related to his holdings, but specific dollar amounts and the exact nature of the transactions are not provided in this summary.

Why It Matters

This filing indicates potential shifts in insider holdings, which can sometimes signal changes in management's confidence in the company's future prospects.

Risk Assessment

Risk Level: low — Form 4 filings typically report routine changes in insider ownership and do not inherently represent significant risk.

Key Players & Entities

• Richard K. Prins (person) — Reporting Person
• IGC Pharma, Inc. (company) — Issuer
• 0001326205 (company) — Issuer CIK
• 0001185185-26-001286 (filing_id) — SEC Accession Number

FAQ

Filing Documents

• ownership.html (4)
• ownership.xml (4) — 9KB
• 0001185185-26-001286.txt ( ) — 11KB

From the Filing

SEC FORM 4 SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10. 1. Name and Address of Reporting Person * PRINS RICHARD K (Last) (First) (Middle) 10224 FALLS ROAD (Street) POTOMAC MARYLAND 20854 (City) (State) (Zip) UNITED STATES (Country) 2. Issuer Name and Ticker or Trading Symbol IGC Pharma, Inc. [ IGC ] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X Director 10% Owner Officer (give title below) Other (specify below) 2a. Foreign Trading Symbol 3. Date of Earliest Transaction (Month/Day/Year) 04/01/2026 6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person 4. If Amendment, Date of Original Filed (Month/Day/Year) Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 04/01/2026 M 100,000 (1) A $ 0.0 1,471,251 D Common Stock 04/01/2026 M 70,000 (2) A $ 0.0 1,541,251 D Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Restricted Stock Units (3) 04/01/2026 M 100,000 (1) (1) (1) Common Stock 100,000 $ 0.0 0 D Restricted Stock Units (3) 04/01/2026 M 70,000 (2) (2) (2) Common Stock 70,000 $ 0.0 70,000 D Explanation of Responses: 1. On June 20, 2023, the Reporting Person was granted RSUs subject to vesting equally over three years starting on March 31, 2024. 2. On March 13, 2024, the Reporting Person was granted RSUs subject to vesting equally over three years starting March 2025. 3. Each restricted stock unit represents a right to receive one share of IGC common stock. /s/ Richard Prins 04/06/2026 ** Signature of Reporting Person Date Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. * If the form is filed by more than one reporting person, see Instruction 4 (b)(v). ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. * Form 4: SEC 1474 (03-26)